SEP-380135

SEP-380135 · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SEP-380135, covering 2026-01-15 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode [Phase 1]